Pooled mutation‐barcoding library, containing 119 PIK3CA mutations and controls (Table S5), were conducted to achieve precise annotation of impactful PIK3CA mutations that determine the proliferation ability of HER2+ mammary cancer cells and drug responses under different treatments (Figure 3A). Here, ERBB2 is linked to breast cancer.